| Literature DB >> 22905720 |
Tatiana Nedelko1, Heike Kollmus, Frank Klawonn, Sabine Spijker, Lu Lu, Manuela Heßman, Rudi Alberts, Robert W Williams, Klaus Schughart.
Abstract
BACKGROUND: There is strong but mostly circumstantial evidence that genetic factors modulate the severity of influenza infection in humans. Using genetically diverse but fully inbred strains of mice it has been shown that host sequence variants have a strong influence on the severity of influenza A disease progression. In particular, C57BL/6J, the most widely used mouse strain in biomedical research, is comparatively resistant. In contrast, DBA/2J is highly susceptible.Entities:
Mesh:
Year: 2012 PMID: 22905720 PMCID: PMC3479429 DOI: 10.1186/1471-2164-13-411
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1BXD strains exhibit variable kinetics of weight loss and survival after infection with Influenza A virus. Mice from 53 BXD and parental strains were infected intra-nasally with 2 × 103 FFU of PR8 virus. Weight loss and survival of infected mice was followed over a period of 13 days. Mortality includes mice that were sacrificed because they had lost more than 25% of body weight. Three phenotypic groups can be distinguished: in the first group (A), all infected mice within a given BXD strain survived, in the second group (B) less than 50% of infected mice within a given BXD strain died, in the third group (C), more than 50% of infected mice within a given BXD strain died. From the weight loss curve of the second and third group it also becomes obvious that non-surviving mice were all approaching the 75% body weight loss endpoint before dying.
Figure 2Principal component analysis of all body weight traits reveals two distinct groups. PCA loading plot of principal components PC1 and PC2 (Supplement Figure 2) for body weight traits form day 1 to day 7 p.i. shows two distinct groups. The variation of body weight loss at day 3 to day 7 (ID 13007 to ID 13011) are mainly represented by factor 1. On the other hand, variation of body weight loss at day 1 (ID 13005) and 2 (ID 13006) are most likely explained by factor 2.
Figure 3Genome-wide linkage analysis for body weight loss after H1N1 infection identifies time-dependent QTLs. Analysis of body weight from day 1 (A), day 2 (B), day 3 (C), day 4 (D), day 5 (E), day 6 (F) and day 7 (G) after PR8 infection revealed time-dependent QTLs. A significant QTL is located on chromosome 5 and suggestive QTLs are observed on chromosomes 2, 6, 9, 10, 16 and 17. Dead or euthanized mice were included for the analysis by manually setting their body weight to 75%. Interval mapping is shown across the entire genome as blue line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
Figure 4Genome-wide linkage scan for PC1 and PC2 body weight loss. Interval mapping of principle component PC1 (A) for body weight loss traits at day 1 to 7 after PR8 infection shows significant QTLs on chromosome 5 and suggestive QTLs on chromosomes 16 and 17. Interval mapping of PC2 (B) for body weight loss traits reveals no significant QTLs and a suggestive QTL on chromosome 13. Interval mapping is shown across the entire genome as blue line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
Figure 5Genome-wide linkage scan for survival rate and mean time to death confirms QTLs on chromosomes 5 and 19. Interval mapping of survival rates (in %) after PR8 infection at day 7 (A), day 8 (B) and day 11 (C) show significant QTLs on chromosomes 5 and 19. Suggestive QTLs are observed on chromosomes 2, 3, 10, 16 and 17. Interval mapping using mean time to death confirmed the significant QTL on chromosome 5 and revealed suggestive QTLs on chromosomes 2, 17 and 19 (D). Interval mapping is shown across the entire genome as blue line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
Figure 6Composite interval mapping indicates interactions of QTLs on chromosomes 5 and 19. The influence of the markers rs13483633 on chromosome 19 (A, B) and rs13478587 on chromosome 5 (C, D) was factored out and the residual LRS were calculated. Two different traits, survival day 8 (A, C) and mean time of death (B, D) were tested by using the web tool of GeneNetwork. Interval mapping is shown across the entire genome as blue line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
Figure 7Interactions are observed between several QTLs. The graph displays pair-scan results for the trait percent survival at day 8 p.i. (ID13002) (A). The upper left half of the plot highlights any epistatic interactions, the lower right half provides a summary of LRS of the full model, representing cumulative effects of linear and non-linear terms based on the model ‘Trait Variance = Q1 + Q2 + Q1 x Q2 ’. Subsequently, BXD lines were grouped according to their allele combinations and trait values were compared between groups (B, C). The largest differences are indicated by asterisks. They are highly significant between the respective groups (p < 0.0001). For the various loci, trait values for the following markers were used: Qivr5: rs13478587, chromosome 9: rs6191976, Qivr19: rs13483633. Number of lines and p-values for Qivr5 – chromosome 9: D2/D2: n = 17, D2/B6: n = 17, B6/D2: n = 6, B6/B6 n = 12; D2/D2 vs B6/B6: p < 0.0001, D2/B6 vs B6/B6: p = 0.003. Number of lines and p-values for Qivr5 – Qivr19: D2/D2: n = 18, D2/B6: n = 16, B6/D2: n = 4, B6/B6: n = 14; p-values: D2/D2 vs B6/B6: p < 0.0001, D2/B6 vs B6/B6: p = 0.0008. Abbreviations: D2: DBA/2J, B6: C57BL/6J.
Figure 8Detailed maps of QTLs contributing to host susceptibility and resistance to PR8 influenza A infection. Interval mapping was performed for chromosomes 2 (A), 5 (B), 16 (C), 17 (D) and 19 (E). The critical intervals were selected based on the peak shapes and the bootstrap signals: Qivr2-1 (56–68 Mb), Qivr5 (140–153 Mb), Qivr16 (64–78 Mb), Qivr17-2 (30–44 Mb) and Qivr19 (37–45 Mb). The Qivr intervals are delineated by red arrows. The yellow bars represent the frequencies of peak LRS using bootstrap analysis. The multicolored chatters along the top of the graph are hyperlinks to sites with additional genetic and sequence information. The orange chatter along the x-axis indicates the density of SNPs present in the BXD strains. Interval mapping is shown across the entire genome as blue line representing the LRS scores; green line: DBA/2J alleles increase trait values; red line: C57BL/6J alleles increase trait values. Upper x-axis shows mouse chromosomes, lower x-axis shows physical map in mega bases for each chromosome, y-axis represents LRS score. The horizontal lines mark the genome-wide significant thresholds at p<0.05 (red line) and suggestive thresholds at p<0.37 (gray line).
Candidate genes in mapped QTL intervals
| 56-68 Mb | D2 | 72 | 24 (19) | - | 4 / 0 | 6 | 3 | |
| 140-153 Mb | D2 | 179 | 83 (57) | - | 9 / 0 | 13 | 10 | |
| 64-78 Mb | B6 | 52 | 12 (7) | 1a | 5 / 0 | 4 | 4 | |
| 30-44 Mb | B6 | 370 | 158 (104) | 1b | 58 / 4c-f | 32 | 40 | |
| 37– 45 Mb | D2 | 161 | 51 (30) | 1g | 14 / 1h | 11 | 4 |
Up- or down-regulated genes were defined as genes that exhibited at least a 1.5 difference change in expression levels in lungs of infected mice compared to the non-infected controls. Genes were defined as differentially expressed exhibiting at least a 1.5 difference in expression changes in infected lungs of C57BL/6J and DBA/2J. Genes with sequence variations: aRobo1, Lst1, cBrd2, dH2-Ab1, H2-Bl, fRpp21, gTctn3, hDhdpsI. Abbreviations: FS: frame shift in coding region, SNP: single nucleotide polymorphism, cis-eQTL: cis regulated expression QTL, B6: C57BL/6J, D2: DBA/2J.
GO-terms and functions observed in knock-out mice of 31 potential candidates from QTL intervals
| integrin beta 6 | Integrin-mediated signaling pathway, inflammatory response, cell-matrix adhesion | Baldness associated with macrophage infiltration of skin, exaggerated pulmonary inflammation, impaired mucosal mast cell response to nematode infection. | ns (1) | ||
| interferon induced with helicase C domain 1 | Response to virus, innate immune response, regulation of apoptosis, RIG-I-like receptor signaling pathway | Increased virus-associated morbidity and mortality, decreased cytokine response to several viral infection. | ns (5) | ||
| eukaryotic translation initiation factor 3, subunit B | Translation, translation initiation | NA | ns (1) | ||
| sidekick homolog 1 (chicken) | Cell adhesion | NA | ns (1) | ||
| eukaryotic translation initiation factor 2 alpha kinase 1 | Negative regulation of translation, response to stress, negative regulation of cell proliferation, regulation of eIF2 alpha phosphorylation by heme | Enlarged heart size, abnormal red blood cell development, morphology, physiology with macrocytic anemia. | ns (1) | ||
| ring finger protein (C3H2C3 type) 6 | Ubiquitin-dependent protein catabolic process, positive regulation of transcription, DNA-dependent | NA | ns (2) | ||
| roundabout homolog 1 (Drosophila) | Cell differentiation, axon guidance, chemotaxis | Neonatal death, aphagia, delayed lung maturation and bronchial hyperplasia. | insertion | ||
| Nuclear receptor interaacting protein 1 | Regulation of transcription | Female infertility due to ovulation failure. Male and female mice are smaller than wild-type littermates. | ns (1) | ||
| ubiquitin specific peptidase 25 | Ubiquitin-dependent protein catabolic process | NA | ns (1) | ||
| crystallin, alpha A | Negative regulation of apoptosis, negative regulation of caspase activity, lens fiber cell morphogenesis | Small lenses that develop progressive opacity beginning in the nucleus. | no | ||
| SNF1-like kinase | Negative regulation of transcription from RNA polymerase II promoter, regulation of cell differentiation, protein kinase cascade | NA | no | ||
| membrane-associated ring finger (C3HC4) 2 | Endocytosis, biological process | NA | no | ||
| TAP binding protein | Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; defense response | Reduced and thermolabile MHC class I surface expression due to impaired peptide loading with stabilizing peptides, impaired T cell selection, altered NK repertoire, lower CD8+ T cell numbers, impaired responses to select class I-restricted antigens. | ns (1) | ||
| histocompatibility 2, O region alpha locus | Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II, regulation of T cell differentiation, Graft-versus-host disease, viral myocarditis | Abnormal antigen presentation via MHC class II, enhanced selection of CD4+ single positive thymocytes. Mice homozygous for a different knock-out allele show increased serum IgG1 levels. | ns (1) | ||
| histocompatibility 2, class II, locus DMa | Antigen processing and presentation of exogenous peptide antigen via MHC class II, positive regulation of T cell differentiation, positive regulation of immune response, Graft-versus-host disease, viral myocarditis | Impaired antigen presenting cell function, poor IgG responses to T-dependent antigens, reduced numbers of mature CD4+ T cells, increased susceptibility to Leishmania major infection. | ns (2) | ||
| transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | Antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent; positive regulation of T cell mediated cytotoxicity, protection from natural killer cell mediated cytotoxicity | No CD8+ T cells, although numbers of CD4+ T cells and B cells are normal. | ns (6) | ||
| histocompatibility 2, O region beta locus | Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II, Graft-versus-host disease, viral myocarditis | NA | ns (7) | ||
| histocompatibility 2, class II antigen A, beta 1 | Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II, Graft-versus-host disease, viral myocarditis | Depletion of mature CD4+ T cells, deficiency in cell-mediated immune responses, increased susceptibility to viral infections. | ns (9) | ||
| histocompatibility 2, class II antigen A, alpha | Antigen processing and presentation of exogenous peptide antigen via MHC class II, positive regulation of T cell differentiation, Graft-versus-host disease, viral myocarditis | Lack of cell surface expression of MHC class II molecules on macrophages, decreased CD4-positive T cell number, increased CD8-positive T cell number, thymus hyperplasia, enlarged lymph nodes, altered splenocyte response to staphylococcal enterotoxin B. | ns (10) | ||
| leukocyte specific transcript 1 | Negative regulation of lymphocyte proliferation, immune response, cell morphogenesis | NA | ns (1) deletion | ||
| general transcription factor II H, polypeptide 4 | Regulation of transcription, DNA-dependent | NA | ns (3) | ||
| histocompatibility 2, T region locus 23 | Antigen processing and presentation of peptide antigen via MHC class I, Graft-versus-host disease, viral myocarditis | CD4+ T cells have enhanced responses after infection or immunization, are resistant to suppressor activity mediated by a subset of CD8+ T cells, but are more susceptible to NK cell lysis. | ns (3) | ||
| histocompatibility 2, blastocyst | Antigen processing and presentation | NA | ns (4) stop_L | ||
| ribonuclease P 21 subunit (human) | tRNA processing | NA | ns (1) stop_G | ||
| tripartite motif protein 26 | Biological process | NA | ns (1) | ||
| phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | Inflammatory response, lipid catabolic process | NA | ns (1) | ||
| cytochrome P450, family 39, subfamily a, polypeptide 1 | Lipid metabolic process, oxidation reduction | NA | ns (2) | ||
| sorbin and SH3 domain containing 1 | Transport, focal adhesion assembly, positive regulation of establishment of protein localization in plasma membrane | Decreased triglyceride levels, altered glucose homeostasis, decreased white blood cells and resistance to developing glucose intolerance induced by a high fat diet. | ns (6) | ||
| tectonic family member 3 | Apoptosis | NA | ns (1) insertion (2) | ||
| Hermansky-Pudlak syndrome 1 homolog (human) | Positive regulation of natural killer cell activation, secretion of lysosomal enzymes | Hypopigmentation and increased bleeding time. Impaired natural killer cell function, reduced secretion of kidney lysosomal enzymes, abnormal retinofugal neuronal projections characterize some alleles. | ns (6) | ||
| dynamin binding protein | Intracellular signaling cascade, regulation of Rho protein signal transduction | NA | ns (3) |
The genotype of C57BL/6J was used as reference for the sequence polymorphisms. The knockout mutant phenotype was identified in the MGI Mouse Genome Database. Gene Fign (fidgetin) fulfilled most criteria but was found to be expressed only at late times p.i. (after day 14) and was therefore omitted from the candidate gene list. Abbreviations: KO: knockout mutant, NA: not analyzed, SNP: single nucleotide polymorphism, ns: non-synonymous codons, ORF: open reading frame, stop_G: stop codon gained, stop_L: stop codon lost.